AIMS/HYPOTHESIS: The pancreas and hypothalamus are critical for maintaining nutrient and energy homeostasis, and combined disorders in these organs account for the onset of the metabolic syndrome. Activating transcription factor 3 (ATF3) is an adaptive response transcription factor. The physiological role of ATF3 in the pancreas has been controversial, and its role in the hypothalamus remains unknown. To elucidate the roles of ATF3 in these organs, we generated pancreas- and hypothalamus-specific Atf3 knockout (PHT-Atf3-KO) mice in this study. METHODS: We crossed mice bearing floxed Atf3 alleles with Pdx1-cre mice, in which cre is specifically expressed in the pancreas and hypothalamus, and analysed metabolic variables, pancreatic morphology, food intake, energy expenditure and sympathetic activity in adipose tissue. We also used a hypothalamic cell line to investigate the molecular mechanism by which ATF3 regulates transcription of the gene encoding agouti-related protein (Agrp). RESULTS: Although PHT-Atf3-KO mice displayed better glucose tolerance, neither plasma glucagon nor insulin level was altered in these mice. However, these mice exhibited higher insulin sensitivity, which was accompanied by a leaner phenotype due to decreased food intake and increased energy expenditure. We also observed decreased hypothalamic Agrp expression in PHT-Atf3-KO mice. Importantly, an increase in ATF3 levels is induced by fasting or low glucose in the hypothalamus. We also showed that ATF3 interacts with forkhead box-containing protein, O subfamily 1 (FoxO1) on the Agrp promoter and activates Agrp transcription. CONCLUSIONS/ INTERPRETATION: Our results suggest that ATF3 plays an important role in the control of glucose and energy metabolism by regulating Agrp.
AIMS/HYPOTHESIS: The pancreas and hypothalamus are critical for maintaining nutrient and energy homeostasis, and combined disorders in these organs account for the onset of the metabolic syndrome. Activating transcription factor 3 (ATF3) is an adaptive response transcription factor. The physiological role of ATF3 in the pancreas has been controversial, and its role in the hypothalamus remains unknown. To elucidate the roles of ATF3 in these organs, we generated pancreas- and hypothalamus-specific Atf3 knockout (PHT-Atf3-KO) mice in this study. METHODS: We crossed mice bearing floxed Atf3 alleles with Pdx1-cre mice, in which cre is specifically expressed in the pancreas and hypothalamus, and analysed metabolic variables, pancreatic morphology, food intake, energy expenditure and sympathetic activity in adipose tissue. We also used a hypothalamic cell line to investigate the molecular mechanism by which ATF3 regulates transcription of the gene encoding agouti-related protein (Agrp). RESULTS: Although PHT-Atf3-KO mice displayed better glucose tolerance, neither plasma glucagon nor insulin level was altered in these mice. However, these mice exhibited higher insulin sensitivity, which was accompanied by a leaner phenotype due to decreased food intake and increased energy expenditure. We also observed decreased hypothalamic Agrpexpression in PHT-Atf3-KO mice. Importantly, an increase in ATF3 levels is induced by fasting or low glucose in the hypothalamus. We also showed that ATF3 interacts with forkhead box-containing protein, O subfamily 1 (FoxO1) on the Agrp promoter and activates Agrp transcription. CONCLUSIONS/ INTERPRETATION: Our results suggest that ATF3 plays an important role in the control of glucose and energy metabolism by regulating Agrp.
Authors: Gavin A Bewick; James V Gardiner; Waljit S Dhillo; Aysha S Kent; Nicholas E White; Zoe Webster; Mohammad A Ghatei; Stephen R Bloom Journal: FASEB J Date: 2005-08-11 Impact factor: 5.191
Authors: Katherine E Wortley; Keith D Anderson; Jason Yasenchak; Andrew Murphy; David Valenzuela; Sabrina Diano; George D Yancopoulos; Stanley J Wiegand; Mark W Sleeman Journal: Cell Metab Date: 2005-12 Impact factor: 27.287
Authors: Su Qian; Howard Chen; Drew Weingarth; Myrna E Trumbauer; Dawn E Novi; Xiaoming Guan; Hong Yu; Zhu Shen; Yue Feng; Easter Frazier; Airu Chen; Ramon E Camacho; Lauren P Shearman; Shobhna Gopal-Truter; Douglas J MacNeil; Lex H T Van der Ploeg; Donald J Marsh Journal: Mol Cell Biol Date: 2002-07 Impact factor: 4.272
Authors: Dan Li; Xin Yin; Erik J Zmuda; Christopher C Wolford; Xiaocheng Dong; Morris F White; Tsonwin Hai Journal: Diabetes Date: 2007-12-05 Impact factor: 9.461
Authors: Margaret B Allison; Warren Pan; Alexander MacKenzie; Christa Patterson; Kimi Shah; Tammy Barnes; Wenwen Cheng; Alan Rupp; David P Olson; Martin G Myers Journal: Diabetes Date: 2018-03-13 Impact factor: 9.461